| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| R E Drake, H Xie, G J McHugo, A I Gree. The effects of clozapine on alcohol and drug use disorders among patients with schizophrenia. Schizophrenia bulletin. vol 26. issue 2. 2000-11-03. PMID:10885642. |
the effects of clozapine on alcohol and drug use disorders among patients with schizophrenia. |
2000-11-03 |
2023-08-12 |
human |
| R E Drake, H Xie, G J McHugo, A I Gree. The effects of clozapine on alcohol and drug use disorders among patients with schizophrenia. Schizophrenia bulletin. vol 26. issue 2. 2000-11-03. PMID:10885642. |
although not designed to assess clozapine, this study explored a posteriori the effects of clozapine on alcohol and drug use disorders among schizophrenia patients. |
2000-11-03 |
2023-08-12 |
human |
| R E Drake, H Xie, G J McHugo, A I Gree. The effects of clozapine on alcohol and drug use disorders among patients with schizophrenia. Schizophrenia bulletin. vol 26. issue 2. 2000-11-03. PMID:10885642. |
among 151 patients with schizophrenia or schizoaffective disorder and co-occurring substance use disorder who were studied in a dual-disorder treatment program, 36 received clozapine during the study for standard clinical indications. |
2000-11-03 |
2023-08-12 |
human |
| W T Carpenter, A Breier, R W Buchanan, B Kirkpatrick, P Shepard, E Weine. Mazindol treatment of negative symptoms. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 23. issue 4. 2000-11-01. PMID:10989263. |
results for deficit and non-deficit schizophrenia subjects were similar, and were not affected by whether concurrent the antipsychotic drug treatment was clozapine, fluphenazine, or haloperidol. |
2000-11-01 |
2023-08-12 |
human |
| R Rosenheck, J Cramer, G Jurgis, D Perlick, W Xu, J Thomas, W Henderson, D Charne. Clinical and psychopharmacologic factors influencing family burden in refractory schizophrenia. The Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia. The Journal of clinical psychiatry. vol 61. issue 9. 2000-10-25. PMID:11030488. |
the department of veterans affairs cooperative study group on clozapine in refractory schizophrenia. |
2000-10-25 |
2023-08-12 |
Not clear |
| R Rosenheck, J Cramer, G Jurgis, D Perlick, W Xu, J Thomas, W Henderson, D Charne. Clinical and psychopharmacologic factors influencing family burden in refractory schizophrenia. The Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia. The Journal of clinical psychiatry. vol 61. issue 9. 2000-10-25. PMID:11030488. |
this study compares the effect of clozapine and haloperidol and identifies other factors related to family burden as experienced by relatives of patients with refractory schizophrenia (dsm-iii-r). |
2000-10-25 |
2023-08-12 |
Not clear |
| S J Tsai, C J Hong, Y W Yu, C H Lin, H L Song, H C Lai, K H Yan. Association study of a functional serotonin transporter gene polymorphism with schizophrenia, psychopathology and clozapine response. Schizophrenia research. vol 44. issue 3. 2000-10-11. PMID:10962219. |
the present study tested the hypothesis that a biallelic polymorphism in the 5' regulatory region of the 5-htt gene (5-httlpr) confers susceptibility to schizophrenia, association with the clinical manifestations of schizophrenia or clozapine response. |
2000-10-11 |
2023-08-12 |
Not clear |
| S J Tsai, C J Hong, Y W Yu, C H Lin, H L Song, H C Lai, K H Yan. Association study of a functional serotonin transporter gene polymorphism with schizophrenia, psychopathology and clozapine response. Schizophrenia research. vol 44. issue 3. 2000-10-11. PMID:10962219. |
the results demonstrated that the 5-httlpr variants did not play a major role in the susceptibility, clinical manifestations or clozapine response in schizophrenia. |
2000-10-11 |
2023-08-12 |
Not clear |
| A Schuld, M Kühn, M Haack, T Kraus, D Hinze-Selch, C Lechner, T Pollmäche. A comparison of the effects of clozapine and olanzapine on the EEG in patients with schizophrenia. Pharmacopsychiatry. vol 33. issue 3. 2000-10-02. PMID:10855462. |
a comparison of the effects of clozapine and olanzapine on the eeg in patients with schizophrenia. |
2000-10-02 |
2023-08-12 |
Not clear |
| A Schuld, M Kühn, M Haack, T Kraus, D Hinze-Selch, C Lechner, T Pollmäche. A comparison of the effects of clozapine and olanzapine on the EEG in patients with schizophrenia. Pharmacopsychiatry. vol 33. issue 3. 2000-10-02. PMID:10855462. |
we examined the eegs of patients with schizophrenia treated with either olanzapine (n = 9) or clozapine (n = 9) prior to medication and 3 to 7 weeks afterwards. |
2000-10-02 |
2023-08-12 |
Not clear |
| P M Llorca, C Lancon, J Farisse, J C Scott. Clozapine and negative symptoms. An open study. Progress in neuro-psychopharmacology & biological psychiatry. vol 24. issue 3. 2000-09-25. PMID:10836486. |
clozapine, the first atypical antipsychotic, has demonstrated an efficacy in the treatment of resistant schizophrenia. |
2000-09-25 |
2023-08-12 |
Not clear |
| P M Llorca, C Lancon, J Farisse, J C Scott. Clozapine and negative symptoms. An open study. Progress in neuro-psychopharmacology & biological psychiatry. vol 24. issue 3. 2000-09-25. PMID:10836486. |
the authors studied the efficacy of clozapine in an open study in a population of 51 patients, who met the dsm iv criteria for schizophrenia. |
2000-09-25 |
2023-08-12 |
Not clear |
| P M Llorca, C Lancon, J Farisse, J C Scott. Clozapine and negative symptoms. An open study. Progress in neuro-psychopharmacology & biological psychiatry. vol 24. issue 3. 2000-09-25. PMID:10836486. |
), we try to identify the specificity of the action of clozapine on the different symptomatic dimensions of schizophrenia. |
2000-09-25 |
2023-08-12 |
Not clear |
| M Mark, R Magnezi, O Luxenburg, M Siebzehner, J Sheme. [Clozapine in the treatment of schizophrenia]. Harefuah. vol 137. issue 5-6. 2000-09-25. PMID:10959316. |
[clozapine in the treatment of schizophrenia]. |
2000-09-25 |
2023-08-12 |
Not clear |
| M L Lu, H Y Lane, K P Chen, M W Jann, M H Su, W H Chan. Fluvoxamine reduces the clozapine dosage needed in refractory schizophrenic patients. The Journal of clinical psychiatry. vol 61. issue 8. 2000-09-14. PMID:10982203. |
concomitant fluvoxamine use can potentially reduce the dosage of clozapine needed in treatment-refractory patients with schizophrenia. |
2000-09-14 |
2023-08-12 |
Not clear |
| S Frangou, M Lewi. Atypical antipsychotics in ordinary clinical practice: a pharmaco-epidemiologic survey in a south London service. European psychiatry : the journal of the Association of European Psychiatrists. vol 15. issue 3. 2000-08-24. PMID:10881220. |
the aim of this paper was to examine the use of atypical antipsychotics in clinical care, by means of a survey of prescribing practices for clozapine, risperidone, olanzapine, sertindole and quetiapine for all patients treated for dsm-iv schizophrenia within a psychiatric service. |
2000-08-24 |
2023-08-12 |
Not clear |
| S Frangou, M Lewi. Atypical antipsychotics in ordinary clinical practice: a pharmaco-epidemiologic survey in a south London service. European psychiatry : the journal of the Association of European Psychiatrists. vol 15. issue 3. 2000-08-24. PMID:10881220. |
the new atypical antipsychotics appear to be replacing older neuroleptics as the first-line treatment of schizophrenia while clozapine is mostly reserved for poor responders. |
2000-08-24 |
2023-08-12 |
Not clear |
| Z A Sharif, A Raza, S S Ratakond. Comparative efficacy of risperidone and clozapine in the treatment of patients with refractory schizophrenia or schizoaffective disorder: a retrospective analysis. The Journal of clinical psychiatry. vol 61. issue 7. 2000-08-21. PMID:10937608. |
comparative efficacy of risperidone and clozapine in the treatment of patients with refractory schizophrenia or schizoaffective disorder: a retrospective analysis. |
2000-08-21 |
2023-08-12 |
Not clear |
| S Raskin, G Katz, Z Zislin, H Y Knobler, R Durs. Clozapine and risperidone: combination/augmentation treatment of refractory schizophrenia: a preliminary observation. Acta psychiatrica Scandinavica. vol 101. issue 4. 2000-07-14. PMID:10782556. |
clozapine and risperidone: combination/augmentation treatment of refractory schizophrenia: a preliminary observation. |
2000-07-14 |
2023-08-12 |
Not clear |
| S Raskin, G Katz, Z Zislin, H Y Knobler, R Durs. Clozapine and risperidone: combination/augmentation treatment of refractory schizophrenia: a preliminary observation. Acta psychiatrica Scandinavica. vol 101. issue 4. 2000-07-14. PMID:10782556. |
clozapine and risperidone were the first two antipsychotic drugs of a new class of agents for the pharmacotherapy of schizophrenia. |
2000-07-14 |
2023-08-12 |
Not clear |